Literature DB >> 22294262

Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis.

Yasumasa Kanai1, Takahiro Satoh, Ken Igawa, Hiroo Yokozeki.   

Abstract

Psoriasis is a chronic skin disease mediated by Th17 and/or Th1 cells. Tim-3 is a cell surface molecule preferentially expressed on Th17 and Th1 cells. The interaction of Tim-3 with Tim-3 ligand inhibits cytokine production. To assess whether T cells in psoriasis have functional abnormalities, expression of cell surface Tim-3 on blood T cells producing interleukin-17 (Th17/Tc17 cells) or interferon-γ (Th1/Tc1 cells) was examined by flow cytometry. Psoriasis patients had higher numbers of Th17 and Tc17 cells, as well as Th1 and Tc1 cells, than healthy donors. However, Th17, Th1 and Tc1 cells in psoriasis did not efficiently express Tim-3 upon activation, compared with those from atopic dermatitis and healthy donors. Tim-3- cells showed more potent cytokine production than Tim-3+ cells. Impaired Tim-3 expression allows Th17, Th1 and Tc1 cells to escape from Tim-3-mediated negative regulatory systems and may contribute to the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22294262     DOI: 10.2340/00015555-1285

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  13 in total

Review 1.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Amygdalin analogues inhibit IFN-γ signalling and reduce the inflammatory response in human epidermal keratinocytes.

Authors:  Iole Paoletti; Vincenza De Gregorio; Adone Baroni; Maria Antonietta Tufano; Giovanna Donnarumma; Juan Jesus Perez
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 3.  Role of Tim-3 in hepatitis B virus infection: An overview.

Authors:  Yuan Liu; Li-Fen Gao; Xiao-Hong Liang; Chun-Hong Ma
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  Regulation of osteoclastogenesis through Tim-3: possible involvement of the Tim-3/galectin-9 system in the modulation of inflammatory bone destruction.

Authors:  Kanako Moriyama; Akiko Kukita; Yin-Ji Li; Norihisa Uehara; Jing-Qi Zhang; Ichiro Takahashi; Toshio Kukita
Journal:  Lab Invest       Date:  2014-09-29       Impact factor: 5.662

5.  Upregulation of Tim-3 on CD4(+) T cells is associated with Th1/Th2 imbalance in patients with allergic asthma.

Authors:  Fei Tang; Fukun Wang; Liyun An; Xianling Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms.

Authors:  Lauren Y Cao; Jin-Sung Chung; Takahiro Teshima; Lawrence Feigenbaum; Ponciano D Cruz; Heidi T Jacobe; Benjamin F Chong; Kiyoshi Ariizumi
Journal:  J Invest Dermatol       Date:  2016-05-25       Impact factor: 8.551

7.  Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Authors:  Yuanxing Liu; Haofeng Ji; Yu Zhang; Xiuda Shen; Feng Gao; Xiangyi He; Gabriella A Li; Ronald W Busuttil; Vijay K Kuchroo; Jerzy W Kupiec-Weglinski
Journal:  J Hepatol       Date:  2014-10-31       Impact factor: 25.083

Review 8.  The Potential Role of Inhibitory Receptors in the Treatment of Psoriasis.

Authors:  Neha Shah; Sabina Sandigursky; Adam Mor
Journal:  Bull Hosp Jt Dis (2013)       Date:  2017-05

Review 9.  Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

Authors:  Ana C Anderson; Nicole Joller; Vijay K Kuchroo
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus.

Authors:  Lairun Jin; Ran Bai; Jun Zhou; Wei Shi; Liang Xu; Jun Sheng; Hui Peng; Yuelong Jin; Hui Yuan
Journal:  Med Sci Monit Basic Res       Date:  2018-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.